type 2 diabetes
Conditions
Interventions
change premix insulin to insulin glargine and add sitagliptin
continue premix insulin and add sitagliptin
Sponsors
yokohama city university school of medicine endcrinology and metabolism
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: type 2 diabetes 6.5<=HbA1c(JDS)<10.0 or uncontrolable use premixed insulin for 3 months
Exclusion criteria
Exclusion criteria: poor hepatitis Cr>=2.0 use glinide use two or more kind of insulins
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c before and after intervention | — |
Countries
Japan
Outcome results
None listed